// App-Quantinova.ai

5065 : Impact of Inherited Thrombophilia Factors On Thrombotic Risk in Patients with Newly Diagnosed BCR- Abl (-) Myeloproliferative Disorders; Finally a Role of MTHFR- C677T Polymorphism?

Researchers

Presenter

  • Valia Papageorgiou

Principal Investigators

  • Konstantinos Tsepanis

  • Dionysia Theocharidou

  • Vassilios K Papadopoulos

  • Elissavet Georgiou

  • Smaragda Efraimidou

  • Anna Kioumi

Medical Centers

  • Hematology Dept, Papageorgiou Hospital, Thessaloniki, Greece

  • Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece

  • Hematology, Gennimata General Hospital, Thessaloniki, Greece

  • Hematology Dept, Papageorgiou Hospital, Thessaloniki, Greece

Locations

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myeloid neoplasms

  • Essential thrombocythemia

  • Inherited thrombophilia

  • Polycythemia vera

  • Venous thrombosis

  • Myelofibrosis

Biomarkers

  • Breakpoint Cluster Region

  • Ph chromosome

  • Platelet count

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved